← Back to Search

Benzodiazepine

Music vs Midazolam for Pre-Surgery Anxiety

Phase 1 & 2
Recruiting
Led By Veena Graff, MD, MS
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-2 minutes before conducting golden moment for nerve block placement and immediately after nerve block placement (less than 1 minute after)
Awards & highlights
No Placebo-Only Group

Summary

This trial compares music to a drug to reduce pre-surgery anxiety before a nerve block.

Who is the study for?
This trial is for adults over 18 who can consent to receiving a nerve block before surgery for anesthesia or pain control. It's not for those allergic to midazolam, with severe psychiatric conditions, extreme anxiety (STAI-6 score >50), kidney issues, pregnant/breastfeeding women, or coagulation disorders.
What is being tested?
The study compares the effects of listening to music versus taking midazolam on reducing anxiety before getting a single-shot nerve block as preparation for surgery.
What are the potential side effects?
Midazolam may cause drowsiness, light-headedness, confusion, blurred vision and nausea. Music has no known side effects but might not be effective in reducing anxiety for everyone.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-2 minutes before conducting golden moment for nerve block placement and immediately after nerve block placement (less than 1 minute after)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-2 minutes before conducting golden moment for nerve block placement and immediately after nerve block placement (less than 1 minute after) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in STAI-6 Scores From Post to Pre
Anxiety
Secondary study objectives
Block Times - time it took to do the block
Evaluation of Difficulties in Communication From Provider to Patient and Patient to Provider
Patient Satisfaction Scores of the Experience During Procedure
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Music groupActive Control1 Intervention
self-selected music
Group II: Midazolam groupActive Control1 Intervention
IV midazolam (1mg to 2mg max)

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,084 Previous Clinical Trials
42,726,373 Total Patients Enrolled
Veena Graff, MD, MSPrincipal InvestigatorUniversity of Pennsylvania, Anesthesiology and Critical Care
1 Previous Clinical Trials
160 Total Patients Enrolled

Media Library

Midazolam (Benzodiazepine) Clinical Trial Eligibility Overview. Trial Name: NCT05610969 — Phase 1 & 2
Botox Research Study Groups: Music group, Midazolam group
Botox Clinical Trial 2023: Midazolam Highlights & Side Effects. Trial Name: NCT05610969 — Phase 1 & 2
Midazolam (Benzodiazepine) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05610969 — Phase 1 & 2
Botox Patient Testimony for trial: Trial Name: NCT05610969 — Phase 1 & 2
~37 spots leftby Jan 2026